Covista Appoints Amelia Manning as President of Chamberlain University
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 13 2026
0mins
Should l Buy CVSA?
Covista announced that Amelia Manning has been named president of Chamberlain University, effective May 18. Most recently, Manning served as the Dean of Tulane University's School of Professional Advancement, where she expanded access to workforce-aligned programs for a broad national audience. Manning succeeds Dr. Karen Cox, who is retiring after more than seven years leading Chamberlain through a period of exceptional growth and academic distinction.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CVSA?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CVSA
Wall Street analysts forecast CVSA stock price to rise
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 118.740
Low
Averages
High
Current: 118.740
Low
Averages
High
About CVSA
Covista Inc., formerly Adtalem Global Education Inc., is a healthcare educator serving across five accredited institutions. Its institutions include American University of the Caribbean School of Medicine, Chamberlain University, Ross University School of Medicine, Ross University School of Veterinary Medicine and Walden University. It provides personalized, tech-enabled access to healthcare careers. Its American University of the Caribbean School of Medicine provides medical education with a focus on clinical experience across its two campuses in Sint Maarten and Preston, United Kingdom. Chamberlain University is an educator for nursing students in the United States, offering nursing and healthcare programs at over 24 campuses nationwide and online. Walden University provides healthcare education for working professionals through a range of online programs which include nursing, health sciences, public health and healthcare leadership.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Covista Launches Healthcare AI Credentials and Future Classroom Development
- Healthcare AI Credentials Live: Covista's healthcare AI credentials, launched in collaboration with Google Cloud, are now available across five institutions, attracting over 3,400 students in the first week, indicating a strong demand for AI fluency in the healthcare sector, which is expected to enhance graduates' competitiveness in the job market.
- Future Classroom Development: Covista is developing an AI-powered future classroom aimed at enhancing educational quality through personalized learning experiences, integrating tools like LearnLM, Gemini, and NotebookLM, with a pilot expected later this year to transform educational methodologies.
- Advisory Council of Industry Leaders: Covista has established the Healthcare AI Readiness Council, bringing together healthcare executives and technology innovators to guide curriculum design, ensuring that AI innovations are closely aligned with clinical practice, thereby producing graduates equipped with essential AI skills.
- Flexible Curriculum Design: The newly launched AI certificate programs are accessible not only to current students but also to alumni and healthcare professionals, with flexible coursework tailored to the schedules of working clinicians, helping them master AI applications in clinical settings to improve patient care quality.
See More
Insider Buying Analysis: Alpha Metallurgical and Covista
- Insider Trading Activity: Director Kenneth S. Courtis of Alpha Metallurgical Resources purchased 25,000 shares of AMR on Monday at $176.23 each, totaling an investment of $4.41 million, indicating confidence in the company's future performance.
- Return on Investment: At today's trading high, Courtis's investment saw an 11.9% return, with AMR reaching a peak price of $197.21, reflecting a positive market response to the stock.
- Historical Purchase Record: Over the past 12 months, Courtis has made four additional purchases of AMR shares, totaling $30.74 million at an average cost of $161.79 per share, demonstrating his sustained optimism about the company's long-term prospects.
- Covista Trading Activity: Director Michael W. Malafronte of Covista bought 36,036 shares on Wednesday at $100.88 each, amounting to a total investment of $3.64 million, with the stock currently up 0.8%, indicating market approval of his investment.
See More
Uplift Appoints New Chief Strategy Officer
- Executive Appointment: Uplift has appointed Evan Trent as Chief Strategy Officer, who will lead the firm's M&A and Integration Value Creation Center from Chicago, expected to enhance the value creation capabilities of portfolio companies through strategic M&A and transformation initiatives.
- Extensive Experience: With over 25 years in the industry, Trent has held multiple senior leadership roles at Covista, where he successfully led major acquisitions and business transformations, providing Uplift with valuable expertise and practical insights for strategic deployment.
- Investment Strategy: Uplift's investment strategy is built on a unique '5-5-5 Framework' targeting companies across five business models and five service sectors, aiming to achieve sustainable value creation through optimized organizational design and go-to-market strategies.
- Market Expansion: Trent's appointment is seen as a significant step for Uplift at this formative stage of growth, with Managing Partner Brad Skaf noting that Trent's experience will aid in institutionalizing and scaling the firm's approach to value creation, thereby enhancing its competitive position in the market.
See More
Covista Launches Healthcare AI Credentials and Future Classroom Development
- Healthcare AI Credentials Live: Covista's healthcare AI credentials, launched in collaboration with Google Cloud, are now available across five institutions, attracting over 3,400 students in the first week, indicating a strong demand for AI fluency in the healthcare sector, which is expected to enhance graduates' competitiveness in the job market.
- Future Classroom Development: Covista is developing an AI-powered future classroom aimed at enhancing educational quality through personalized learning experiences, integrating tools like LearnLM, Gemini, and NotebookLM, with a pilot expected later this year to transform educational methodologies.
- Advisory Council of Industry Leaders: Covista has established the Healthcare AI Readiness Council, bringing together healthcare executives and technology innovators to guide curriculum design, ensuring that AI innovations are closely aligned with clinical practice, thereby producing graduates equipped with essential AI skills.
- Flexible Curriculum Design: The newly launched AI certificate programs are accessible not only to current students but also to alumni and healthcare professionals, with flexible coursework tailored to the schedules of working clinicians, helping them master AI applications in clinical settings to improve patient care quality.
See More
Insider Buying Analysis: Alpha Metallurgical and Covista
- Insider Trading Activity: Director Kenneth S. Courtis of Alpha Metallurgical Resources purchased 25,000 shares of AMR on Monday at $176.23 each, totaling an investment of $4.41 million, indicating confidence in the company's future performance.
- Return on Investment: At today's trading high, Courtis's investment saw an 11.9% return, with AMR reaching a peak price of $197.21, reflecting a positive market response to the stock.
- Historical Purchase Record: Over the past 12 months, Courtis has made four additional purchases of AMR shares, totaling $30.74 million at an average cost of $161.79 per share, demonstrating his sustained optimism about the company's long-term prospects.
- Covista Trading Activity: Director Michael W. Malafronte of Covista bought 36,036 shares on Wednesday at $100.88 each, amounting to a total investment of $3.64 million, with the stock currently up 0.8%, indicating market approval of his investment.
See More
Uplift Appoints New Chief Strategy Officer
- Executive Appointment: Uplift has appointed Evan Trent as Chief Strategy Officer, who will lead the firm's M&A and Integration Value Creation Center from Chicago, expected to enhance the value creation capabilities of portfolio companies through strategic M&A and transformation initiatives.
- Extensive Experience: With over 25 years in the industry, Trent has held multiple senior leadership roles at Covista, where he successfully led major acquisitions and business transformations, providing Uplift with valuable expertise and practical insights for strategic deployment.
- Investment Strategy: Uplift's investment strategy is built on a unique '5-5-5 Framework' targeting companies across five business models and five service sectors, aiming to achieve sustainable value creation through optimized organizational design and go-to-market strategies.
- Market Expansion: Trent's appointment is seen as a significant step for Uplift at this formative stage of growth, with Managing Partner Brad Skaf noting that Trent's experience will aid in institutionalizing and scaling the firm's approach to value creation, thereby enhancing its competitive position in the market.
See More
